4.7 Article

m6Acancer-Net: Identification of m6A-mediated cancer driver genes from gene-site heterogeneous network

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

m5C-Atlas: a comprehensive database for decoding and annotating the 5-methylcytosine (m5C) epitranscriptome

Jiongming Ma et al.

Summary: The paragraph introduces a database called m(5)C-Atlas, which contains information on 166,540 m(5)C sites from 13 different species. It provides data on methylation levels under specific conditions and some novel features for exploring the m(5)C epitranscriptomes.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemical Research Methods

M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers

Shuang Deng et al.

Summary: N-6-methyladenosine (m(6)A) is the most abundant posttranscriptional modification in mammalian mRNA molecules, playing a crucial role. The m(6)A modification is a dynamic and reversible process regulated by a series of writers, erasers, and readers (WERs). Identification of the targets of WERs is particularly important for understanding this dynamic modification.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Oncology

The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor

Mohammad Eskandari et al.

Summary: The study showed that p53 and p21 play important roles in tumorigenesis, while MDM2 and MDM4 are regulators of p53. Patients with TP53 mutations had worse outcomes, and the expression levels of p53, p21, MDM2, and MDM4 were associated with mutation status.

LEUKEMIA & LYMPHOMA (2021)

Article Biochemistry & Molecular Biology

RMVar: an updated database of functional variants involved in RNA modifications

Xiaotong Luo et al.

Summary: Distinguishing disease-related variants within a large number of variants is challenging. The updated RMVar database includes 1,678,126 variants associated with 9 RNA modifications, offering a new perspective on the effects of RM-associated variants on posttranscriptional regulation, as well as integrating disease-related information for further functional studies on genetic variants affecting RNA modifications.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis

Kunqi Chen et al.

Summary: Recent studies suggest a significant role of RNA modifications in biological mechanisms and disease progression. RMDisease is a database containing information on 202,307 human SNPs that may affect RNA modifications, with 4,289 disease-associated SNPs potentially playing a role in disease pathogenesis, along with essential post-transcriptional regulation information.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions

Rose Oughtred et al.

Summary: BioGRID is an open-access database resource that houses protein and genetic interactions from multiple species, serving as a tool for building complex networks to facilitate biomedical discoveries. Curated from primary experimental evidence, BioGRID captures both low-throughput and large high-throughput studies, including protein post-translational modifications and interactions with bioactive small molecules. Additionally, it undertakes themed curation projects in specific aspects of cellular regulation and disease areas.

PROTEIN SCIENCE (2021)

Review Oncology

RNA m6A methylation regulators in ovarian cancer

Jialu Guo et al.

Summary: m6A modification plays a vital role in various diseases, particularly in tumors. Changes in m6A levels and dysregulation of m6A regulators in ovarian cancer can impact disease development and prognosis. Therefore, studying m6A modification and its regulators is crucial for understanding and treating ovarian cancer.

CANCER CELL INTERNATIONAL (2021)

Article Cell Biology

Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia

Xiaoyang Yang et al.

Summary: This study elucidates that upregulation of CCNA1 in AML cells promotes chemoresistance, while downregulation of FOXA2 and the action of EZH2 increase sensitivity of AML cells to drugs.

CELLULAR SIGNALLING (2021)

Article Biochemistry & Molecular Biology

The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets

Damian Szklarczyk et al.

Summary: The STRING database integrates various associations between proteins, including physical interactions and functional associations, by collecting evidence from sources such as literature, databases, computational predictions, and systematic transfers. STRING aims for wide coverage and provides extensive user interface features and querying methods for experimental data.

NUCLEIC ACIDS RESEARCH (2021)

Article Cell Biology

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2

Ping Liu et al.

Summary: The study reveals that high Nrf2 expression in AML is associated with tumor mutation burden, increased gene mutation frequency, and drug resistance risk, by inhibiting MSH2 protein expression leading to DNA MMR deficiency.

CELL DEATH & DISEASE (2021)

Article Hematology

Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia

Daniel R. Richardson et al.

Summary: The ASXL1 and SRSF2 mutations in AML are frequently associated with poor outcomes, especially in patients with preexisting myeloid malignancies. Patients with co-mutations of ASXL1 and SRSF2 have a higher probability of death compared to those with single mutations, with a trend towards inferior overall survival, largely attributable to a high proportion of secondary-AML patients in this cohort.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Chemistry, Medicinal

CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia

Joshua D. Hansen et al.

Summary: Acute myeloid leukemia poses a significant clinical challenge with poor survival and high relapse rates. CC-90009, a novel protein degrader targeting GSPT1 for proteasomal degradation, represents a promising therapeutic approach currently in phase 1 clinical development.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth

Yu-Ling Lee et al.

Summary: The study reveals that the Mediator complex directly interacts with E2A-PBX1 through the MED1 subunit, playing a critical role in regulating E2A-PBX1-dependent gene activation and leukemic cell growth. The findings highlight the functional importance of MED1 in gene-specific transcriptional activation and maintenance of E2A-PBX1-driven leukemia, suggesting potential therapeutic opportunities by targeting MED1 in E2A-PBX1(+) pre-B leukemia.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Oncology

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma

Nanfang Qu et al.

Summary: Liver cancer ranks fifth in terms of incidence worldwide and is the third leading cause of cancer-related deaths. While advancements have been made in treatments such as surgical techniques and immunotherapy, the prognosis for liver cancer patients remains poor. Abnormal expression of m6A-related regulators in HCC has shown potential as diagnostic, prognostic, and therapeutic markers.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

The crucial roles of N6-methyladenosine (m6A) modification in the carcinogenesis and progression of colorectal cancer

Zhihao Fang et al.

Summary: Recent studies have shown the association between changes in m(6)A levels and dysregulation of m(6)A regulatory proteins with CRC carcinogenesis and progression. Despite the unclear regulatory laws of m(6)A modification in CRC, a better understanding of these mechanisms could benefit the diagnosis and therapy of CRC.

CELL AND BIOSCIENCE (2021)

Review Oncology

Functions of RNA N6-methyladenosine modification in acute myeloid leukemia

Xue Zheng et al.

Summary: This article summarizes the role of N-6-methyladenosine (m(6)A) in the pathogenesis of AML, highlighting its critical involvement in gene expression regulation and potential as a therapeutic target for AML.

BIOMARKER RESEARCH (2021)

Article Biochemistry & Molecular Biology

m6A-express: uncovering complex and condition-specific m6A regulation of gene expression

Teng Zhang et al.

Summary: A novel algorithm, m(6)A-express, was developed to predict condition-specific m(6)A regulation of gene expression, demonstrating high prediction specificity and sensitivity. METTL3 and METTL14 were found to competitively regulate the transcriptional processes by mediating m(6)A-reg-exp of different genes in different cell types, highlighting the complex nature of m(6)A regulation of gene expression. Unique m(6)A-reg-exp patterns were discovered in human brain and intestine tissues, enriched in organ-specific processes.

NUCLEIC ACIDS RESEARCH (2021)

Article Multidisciplinary Sciences

Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells

Xiaona Liu et al.

Summary: The arginine methylation of METTL14 stabilizes the binding of the m(6)A methyltransferase complex to its substrate RNA, thereby promoting global m(6)A modification and mESC endoderm differentiation. The crosstalk between protein methylation and RNA methylation in gene expression is highlighted. The interaction of METTL3/METTL14 with WTAP and substrate RNA is enhanced by arginine methylation of METTL14 at R255 by PRMT1, promoting m(6)A methylation activity of the complex.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Methylation of dual-specificity phosphatase 4 controls cell differentiation

Hairui Su et al.

Summary: This study demonstrates that DUSP4 inactivates p38 kinase to promote megakaryocyte differentiation, with PRMT1-mediated methylation triggering its ubiquitinylation. Elevated levels of p38 MAPK and PRMT1 are associated with thrombocytopenia and poor prognosis in MDS, while inhibition of these enzymes stimulates megakaryopoiesis.

CELL REPORTS (2021)

Article Cell Biology

EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia

Zhuanzhen Zheng et al.

Summary: Research showed that the expression levels of EZH2 and EHMT2 varied in MDS patients and NHD13 mice, and their association with the transcription level of DLX5 and cell proliferation was observed.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

The emerging role of RNA N6-methyladenosine methylation in breast cancer

Fangchao Zheng et al.

Summary: The m6A modification plays a crucial role in breast cancer development, with potential for serving as a therapeutic target. Studies on the biological function and prognostic value of m6A modification in breast cancer are ongoing.

BIOMARKER RESEARCH (2021)

Article Hematology

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Inge van der Werf et al.

Summary: Splicing factor (SF) mutations in patients with acute myeloid leukemia (AML) are associated with unfavorable clinical features, adverse risk factors, and shorter survival. SF3B1 mutations indicate relatively poor prognosis, especially in certain risk groups. The prognostic value of RUNX1 mutations seems to be limited to its co-occurrence with SF mutations.

BLOOD ADVANCES (2021)

Article Hematology

KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2

Siyuan Xu et al.

Summary: Epigenetic abnormalities play a critical role in cancer, specifically in diseases like AML where aberrant fusion proteins drive the disease. The loss of KDM5A leads to differentiation and growth retardation in APL NB4 cells, by suppressing the expression of key target genes. Inhibition of KDMSA could greatly enhance differentiation in NB4 cells, suggesting a potential therapeutic target in APL treatment.

BLOOD ADVANCES (2021)

Article Oncology

The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells

Sonia Nunez-Vazquez et al.

Summary: Fluorizoline is a compound that binds prohibitin, triggering apoptosis and inhibiting mitophagy in various cell lines. It can act on both Parkin-dependent and Parkin-independent mitophagy processes.

ONCOGENESIS (2021)

Article Oncology

Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia

Camila Prieto et al.

Summary: The RNA-binding proteins RBMX and RBMXL1 were identified as AML tumor promoters that control leukemia cell survival by regulating chromatin state through the downstream target CBX5. This study reveals a new mechanism for RBPs directly promoting transcription and suggests RBMX, RBMXL1, and CBX5 as potential therapeutic targets in myeloid malignancies.

NATURE CANCER (2021)

Review Oncology

Importance of N6-methyladenosine RNA modification in lung cancer (Review)

Yueyang Wang et al.

Summary: m(6)A modification plays a significant role in RNA metabolism and cancer pathogenesis. Despite advancements in lung cancer treatment options, the survival rate for patients remains low. The exact mechanism and importance of m(6)A RNA methylation in the pathogenesis of lung cancer are still unclear.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Landscape and Regulation of m6A and m6Am Methylome across Human and Mouse Tissues

Jun'e Liu et al.

MOLECULAR CELL (2020)

Article Biochemistry & Molecular Biology

LDB1 Enforces Stability on Direct and Indirect Oncoprotein Partners in Leukemia

Justin H. Layer et al.

MOLECULAR AND CELLULAR BIOLOGY (2020)

Review Cell & Tissue Engineering

N6-methyladenosine (m6A)RNAmodification in cancer stem cells

Zhonghua Ma et al.

STEM CELLS (2020)

Article Cell Biology

The RNA N6-methyladenosine modification landscape of human fetal tissues

Shan Xiao et al.

NATURE CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemical Research Methods

FunDMDeep-m6A: identification and prioritization of functional differential m6A methylation genes

Song-Yao Zhang et al.

BIOINFORMATICS (2019)

Article Biochemistry & Molecular Biology

Molecular characterization and clinical relevance of m6A regulators across 33 cancer types

Yongsheng Li et al.

MOLECULAR CANCER (2019)

Article Biochemical Research Methods

Global analysis of N6-methyladenosine functions and its disease association using deep learning and network-based methods

Song-Yao Zhang et al.

PLOS COMPUTATIONAL BIOLOGY (2019)

Letter Cell Biology

Cytoplasmic m6A reader YTHDF3 promotes mRNA translation

Ang Li et al.

CELL RESEARCH (2017)

Article Biochemistry & Molecular Biology

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

Antonio Colaprico et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Biochemistry & Molecular Biology

Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing

Wen Xiao et al.

MOLECULAR CELL (2016)

Article Biochemical Research Methods

m6A-Driver: Identifying Context-Specific mRNA m6A Methylation-Driven Gene Interaction Networks

Song-Yao Zhang et al.

PLOS COMPUTATIONAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

N6-methyladenosine Modulates Messenger RNA Translation Efficiency

Xiao Wang et al.

Article Multidisciplinary Sciences

Genetic mapping uncovers cis-regulatory landscape of RNA editing

Gokul Ramaswami et al.

NATURE COMMUNICATIONS (2015)

Article Medicine, Research & Experimental

Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression

Roberto Ferrarese et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

N6-methyladenosine-dependent regulation of messenger RNA stability

Xiao Wang et al.

NATURE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Editorial Material Genetics & Heredity

The Cancer Genome Atlas Pan-Cancer analysis project

John N. Weinstein et al.

NATURE GENETICS (2013)

Editorial Material Genetics & Heredity

The Genotype-Tissue Expression (GTEx) project

John Lonsdale et al.

NATURE GENETICS (2013)

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Review Biochemistry & Molecular Biology

Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2

Niroshika Keppetipola et al.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)

Article Biochemical Research Methods

Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network

Yongjin Li et al.

BIOINFORMATICS (2010)

Article Biochemistry & Molecular Biology

The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function

David Warde-Farley et al.

NUCLEIC ACIDS RESEARCH (2010)